Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05096026 · ClinicalTrials.gov registry record · NA

Effect of Electronic and Mail Outreach From Primary Care Physicians for COVID-19 Vaccination Among Elderly Patients

A NA study of Vaccination, sponsored by Kaiser Permanente.

Completed
Registry status
NA
Development phase
8,287
Enrollment target
1
Study location

NCT05096026: Completed NA study of Vaccination, sponsored by Kaiser Permanente.

NCT05096026 is a NA study of Vaccination that has completed, run by Kaiser Permanente. The registered enrollment target is 8,287 participants, below the 9,543-participant average among 12 other Vaccination trials with a reported enrollment target (13% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05096026, a NA study of Vaccination, has completed, sponsored by Kaiser Permanente.

COMPLETED
Registry status
NA
Development phase
8,287 participants
Enrollment target
1
Study location

Study Summary

This randomized controlled trial tested the effect of culturally tailored and standard electronic secure messages and mailings from patients' primary care physicians to encourage COVID-19 vaccination among adults aged 65 and older.

Primary Outcome

Days to COVID-19 vaccination

Conditions Studied

Interventions

  • BEHAVIORAL Standard PCP Outreach
  • BEHAVIORAL Culturally Tailored PCP Outreach

Study Locations (1)

California

  • Kaiser Permanente Northern California - Oakland

Trial Details

FieldValue
Enrollment Target 8,287 participants
Start Date 2021-03-29
Est. Completion 2021-08-31
Phase NA
Kaiser Permanente

294 total trials

What the finished NCT05096026 record still lists

NCT05096026 is an interventional study that assigns participants to a tested intervention. Its 8,287 participants enrollment target places it among the larger protocols in the corpus, below the 9,543-participant average among 12 other Vaccination trials with a reported enrollment target (13% lower).

The record links to 1 condition, with Vaccination appearing as the primary indexed condition, and to 2 interventions - of which Standard PCP Outreach is the first listed.

NCT05096026 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05096026 about?

NCT05096026 is a clinical study titled "Effect of Electronic and Mail Outreach From Primary Care Physicians for COVID-19 Vaccination Among Elderly Patients". This randomized controlled trial tested the effect of culturally tailored and standard electronic secure messages and mailings from patients' primary care physicians to encourage COVID-19 vaccination among adults aged 65 and older.

What is the current status of trial NCT05096026?

This trial is currently completed. It is a NA study. The enrollment target is 8,287 participants. The study started on 2021-03-29. Estimated completion is 2021-08-31.

What conditions does trial NCT05096026 study?

This clinical trial studies the following conditions: Vaccination.

What interventions are being tested in trial NCT05096026?

The interventions under investigation include: Standard PCP Outreach (BEHAVIORAL), Culturally Tailored PCP Outreach (BEHAVIORAL).

Who is sponsoring clinical trial NCT05096026?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05096026 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Vaccination

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05096026's enrollment target sits among peer trials

8,287 2nd of 12 the highest of 12 other Vaccination trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Vaccination trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07185828 · 8,286 participants · NA

    Informing Low-acuity Emergency Department Patients of Non-emergent Resources (2)

  • NCT06435806 · 8,200 participants · NA

    Medical Illustration Design Characteristic Evaluation

  • NCT06184945 · 8,100 participants · NA

    Behavioral Economic & Staffing Strategies in the ICU

  • NCT05593484 · 8,060 participants · NA

    School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Alaska

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05096026, the US trial registry maintained by the National Library of Medicine. NCT05096026 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.